Pipeline
The Science
About us
Investors

Hit enter to search or ESC to close

Dr David Stamler Biotech Showcase Presentation

January 8, 2018August 16, 2022 Alterity Therapeutics

Prana Biotechnology JPM investor presentation_updated

2018

Post navigation

Prana meeting with investors at world’s largest healthcare conference in San Francisco

PBT434 poster presented at the 6th International Multiple System Atrophy Conference

Related Posts

Alterity receives a $4.8 million R&D Tax Incentive Refund

January 15, 2020August 16, 2022

AGM 2021 Presentation

November 12, 2021August 16, 2022

Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar

June 13, 2024June 13, 2024

Recent Posts

Alterity Therapeutics Issues Shareholder Newsletter Highlighting Pipeline Advances and Key Upcoming Milestones
Alterity Therapeutics Completes Last Patient Visit in ATH434-201 Phase 2 Clinical Trial in Early-Stage Multiple System Atrophy
Chairman’s Address 2024 Annual General Meeting
AGM 2024 Presentation
Alterity Therapeutics Announces Presentation on Tracking the Progression of Multiple System Atrophy at International Symposium

Recent Comments

Archives

Archives

Categories

ASX Announcements
Chairman's Address
Investor Announcement

Tags

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

LinkedIn
Facebook
X

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065